Sökning: "Lund Institutionen för kliniska vetenskaper"
Visar resultat 6 - 10 av 85 avhandlingar innehållade orden Lund Institutionen för kliniska vetenskaper.
6. Physical Aspects of Thermotherapy - A study of heat transport with a view to treatment optimisation
Sammanfattning : Local treatment with the aim to destruct tissue by heating (thermotherapy) may in some cases be an alternative or complement to surgical methods, and has gained increased interest during the last decade. The major advantage of these, often minimally-invasive methods, is that the disease can be controlled with reduced treatment trauma and complications. LÄS MER
7. Gene Expression Changes and Brain Plasticity after Experimental Stroke
Sammanfattning : Stroke is the most common life-threatening neurological disease and ranks as the third leading cause of death in major industrialized countries. It is also the leading cause of serious long-term disability and about sixty percent of survivors have disabilities in their extremities. LÄS MER
8. Endoplasmic Reticulum Dynamic Structural Changes in Neurons: The Fission-Fusion Phenomena
Sammanfattning : The endoplasmic reticulum (ER) is crucial for protein synthesis and protein maturation, is involved in cell stress and serves in neurons as the major intracellular Ca2+ store. Neuronal ER forms a continuous network of cisterns and tubules extending from soma to a subset of dendritic spines. LÄS MER
9. Endoplasmic reticulum function in dendrites and dendritic spines of hippocampal neurons
Sammanfattning : In the hippocampus, dendritic spines are compartmentalized postsynaptic micro-domains in the excitatory synapse. Subsets of bigger and mushroom-shaped hippocampal dendritic spines contain tubules and cisterns of endoplasmic reticulum (ER) that are connected to the soma and dendrites of the neuron. LÄS MER
10. Experimental Traumatic Brain Injury and Cell Death - in vivo and in vitro aspects
Sammanfattning : Traumatic and ischemic brain damage are major causes of disability and death. While much effort has been spent on developing pharmacological treatments for these conditions, no neuroprotective drugs are in clinical use. LÄS MER